Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06699836 |
| Title | The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER) (CLOVER) |
| Acronym | CLOVER |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | CytoDyn, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope Orange County Lennar Foundation Cancer Center | Irvine | California | 92618 | United States | Details | |
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | United States | Details | |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | United States | Details | |
| Norton Cancer Institute, Brownsboro Hospital Campus | Louisville | Kentucky | 40241 | United States | Details | |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | United States | Details | |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | United States | Details | |
| Summit Cancer Center | Spokane | Washington | 99208 | United States | Details |